Mountain Valley MD Holdings Inc

As of June 30, 2026, Mountain Valley MD Holdings Inc carries a market capitalization of 34.28M, placing it among publicly traded companies globally. Its enterprise value stands at 32.85M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, Mountain Valley MD Holdings Inc has 457.00M shares outstanding.

These figures are as of June 30, 2026. The price-to-sales ratio is 401.55, and the price-to-book ratio stands at 19.79.

These figures are as of June 30, 2026. The EV/Sales ratio of 469.30 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 32.85M versus a market cap of 34.28M, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, Mountain Valley MD Holdings Inc maintains a current ratio of 16.03, meaning it holds 16.0x the short-term assets needed to cover near-term liabilities.

Over the twelve months ended June 30, 2026, Mountain Valley MD Holdings Inc posted a negative return on equity (ROE) of -204.44, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -194.32, reflecting losses generated across the asset base.

As of the close on August 19, 2026, Mountain Valley MD Holdings Inc's stock has gained approximately 225.00% over the past 52 weeks. The 50-day moving average sits at 0.07, while the 200-day moving average is 0.04.

Over the twelve months ended June 30, 2026, Mountain Valley MD Holdings Inc generated 70,000.00 in revenue and converted that into -3.73M in net income, yielding earnings per share of -0.01. EBITDA reached -3.39M, while operating income came in at -2.52M.

These figures are as of June 30, 2026. Total book value stands at 1.73M, with working capital of 1.64M providing operational flexibility.

Mountain Valley MD Holdings Inc produced -2.23M in operating cash flow over the twelve months ended June 30, 2026. After subtracting -30,000.00 in capital expenditures, free cash flow totaled -2.26M - equivalent to -0.01 per share.

These figures cover the twelve months ended June 30, 2026. The operating margin of -3,604.29 and net profit margin of -5,331.43 provide insight into operational efficiency.

These figures cover the twelve months ended June 30, 2026. Free cash flow yield is negative at -8.03: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow.

Mountain Valley MD Holdings Inc's most recent stock split took place on March 4, 2020 with a 8:1 split ratio.

As of June 30, 2026, Mountain Valley MD Holdings Inc has an Altman Z-Score of 136.88, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.